Beth Browning

1.6k total citations
14 papers, 1.3k citations indexed

About

Beth Browning is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Beth Browning has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Beth Browning's work include Cell Adhesion Molecules Research (5 papers), NF-κB Signaling Pathways (5 papers) and Immune Response and Inflammation (3 papers). Beth Browning is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), NF-κB Signaling Pathways (5 papers) and Immune Response and Inflammation (3 papers). Beth Browning collaborates with scholars based in United States, Switzerland and Italy. Beth Browning's co-authors include Linda C. Burkly, Timothy S. Zheng, Jennifer S. Michaelson, Yen‐Ming Hsu, Christine Ambrose, Aniela Jakubowski, Monica Z. Wang, John Lincecum, Lihe Su and Martin Scott and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Beth Browning

14 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beth Browning United States 10 672 538 525 210 192 14 1.3k
Kenji Shibuta Japan 20 573 0.9× 280 0.5× 499 1.0× 159 0.8× 109 0.6× 41 1.4k
S Fuggle United Kingdom 15 458 0.7× 208 0.4× 354 0.7× 393 1.9× 58 0.3× 25 1.2k
Racquel Corpuz United States 10 600 0.9× 115 0.2× 395 0.8× 208 1.0× 77 0.4× 13 1.3k
Renate Gay United States 10 394 0.6× 230 0.4× 240 0.5× 146 0.7× 70 0.4× 13 1.1k
Jung Hwan Yoon South Korea 21 698 1.0× 431 0.8× 204 0.4× 262 1.2× 40 0.2× 63 1.2k
Honghong Sun China 16 760 1.1× 260 0.5× 699 1.3× 84 0.4× 42 0.2× 39 1.3k
Motozo Yamashita Japan 16 1.1k 1.7× 248 0.5× 288 0.5× 64 0.3× 38 0.2× 20 1.6k
Thomas Jamieson United Kingdom 12 526 0.8× 117 0.2× 541 1.0× 275 1.3× 284 1.5× 25 1.5k
Julien Masliah‐Planchon France 18 957 1.4× 348 0.6× 98 0.2× 117 0.6× 151 0.8× 78 1.6k
B E Elliott Canada 17 571 0.8× 187 0.3× 382 0.7× 101 0.5× 256 1.3× 29 1.2k

Countries citing papers authored by Beth Browning

Since Specialization
Citations

This map shows the geographic impact of Beth Browning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Browning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Browning more than expected).

Fields of papers citing papers by Beth Browning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth Browning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Browning. The network helps show where Beth Browning may publish in the future.

Co-authorship network of co-authors of Beth Browning

This figure shows the co-authorship network connecting the top 25 collaborators of Beth Browning. A scholar is included among the top collaborators of Beth Browning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth Browning. Beth Browning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Svensson, Robert, Scott Boiko, Beth Browning, et al.. (2025). Abstract 2894: NTX-452: a non-covalent, potent, selective and highly efficacious WRN inhibitor with best-in-class potential for the treatment of MSI-H tumors. Cancer Research. 85(8_Supplement_1). 2894–2894. 2 indexed citations
2.
Leit, Silvana, David L. Laughton, Suzanne L. Jacques, et al.. (2022). Abstract 589: Discovery of NTX-001, a potent Cbl-b inhibitor with antitumor activity in syngeneic models. Cancer Research. 82(12_Supplement). 589–589. 1 indexed citations
3.
Tampella, Giacomo, Hannah M. Kerns, Deqiang Niu, et al.. (2015). The Tec Kinase–Regulated Phosphoproteome Reveals a Mechanism for the Regulation of Inhibitory Signals in Murine Macrophages. The Journal of Immunology. 195(1). 246–256. 16 indexed citations
4.
Cho, Samuel K., Yan Ren, Ling Ling Chen, et al.. (2010). Antibodies directed to α6β4 highlight the adhesive and signaling functions of the integrin in breast cancer cell lines. Cancer Biology & Therapy. 9(6). 437–445. 5 indexed citations
5.
Pappu, Bhanu P., Anna Borodovsky, Timothy S. Zheng, et al.. (2008). TL1A–DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. The Journal of Experimental Medicine. 205(5). 1049–1062. 177 indexed citations
6.
Chen, Ling Ling, Samuel K. Cho, Beth Browning, et al.. (2008). Functional Characterization of Integrin α6β4 Adhesion Interactions Using Soluble Integrin Constructs Reveals the Involvement of Different Functional Domains in the β4 Subunit. Cell Communication & Adhesion. 15(4). 317–331. 4 indexed citations
7.
Campbell, Sean, Linda C. Burkly, Joan W. Berman, et al.. (2006). Proinflammatory Effects of Tweak/Fn14 Interactions in Glomerular Mesangial Cells. The Journal of Immunology. 176(3). 1889–1898. 143 indexed citations
8.
Girgenrath, Mahasweta, Christine A. Kostek, Beth Browning, et al.. (2006). TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. The EMBO Journal. 25(24). 5826–5839. 184 indexed citations
9.
Perper, Stuart J., Beth Browning, Linda C. Burkly, et al.. (2006). TWEAK Is a Novel Arthritogenic Mediator. The Journal of Immunology. 177(4). 2610–2620. 132 indexed citations
10.
Michaelson, Jennifer S., Beth Browning, Timothy S. Zheng, et al.. (2005). Tweak induces mammary epithelial branching morphogenesis. Oncogene. 24(16). 2613–2624. 73 indexed citations
11.
Jakubowski, Aniela, Christine Ambrose, Michael Parr, et al.. (2005). TWEAK induces liver progenitor cell proliferation. Journal of Clinical Investigation. 115(9). 2330–2340. 329 indexed citations
12.
Schneider, Pascal, Dian L. Olson, Aubry Tardivel, et al.. (2003). Identification of a New Murine Tumor Necrosis Factor Receptor Locus That Contains Two Novel Murine Receptors for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL). Journal of Biological Chemistry. 278(7). 5444–5454. 101 indexed citations
13.
Jakubowski, Aniela, Beth Browning, Matvey Lukashev, et al.. (2002). Dual role for TWEAK in angiogenic regulation. Journal of Cell Science. 115(2). 267–274. 105 indexed citations
14.
Reimann, Keith A., Wenyu Lin, Sandra L. Bixler, et al.. (1997). A Humanized Form of a CD4-Specific Monoclonal Antibody Exhibits Decreased Antigenicity and Prolonged Plasma Half-Life in Rhesus Monkeys While Retaining Its Unique Biological and Antiviral Properties. AIDS Research and Human Retroviruses. 13(11). 933–943. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026